Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Israel / NCT03932383
Active, not recruiting Not applicable

3D Printer Modified CPAP Mask for Obstructive Sleep Apnea

NCT03932383 · tracked via the Priya Life Science Israel tracker
Sponsor
Beth Israel Deaconess Medical Center
Phase
Not applicable
Started
2018-04-04
Last updated
2020-04-17

Condition(s) studied

Obstructive Sleep Apnea

Investigational drug(s) / intervention(s)

Custom CPAP mask

Custom CPAP mask: Modified CPAP mask based on 3D image capture

Study summary

This is a prospective pilot to investigate the effect of 3D printer customized CPAP masks on the comfort of patients with obstructive sleep apnea.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of obstructive sleep apnea prescribed CPAP * High air leak:1. Absolute high leak duration more than 15% of the use period and / or 2. Absolute high leak over 5% associated with periodic breathing. Exclusion Criteria: * Unable to wear full face CPAP * Unable to provide informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beth Israel Deaconess Medical Center Boston Massachusetts

More Beth Israel Deaconess Medical Center trials in Israel

Statins In Intracerbral Hemorrhage Recruiting
Mechanical Ventilator Adjustments and Patient Dyspnea Starting soon
TRAjectories and CLinical ExpeRiences of ICD Therapy Study Enrolling by invitation
Remote Fetal Monitoring in High Risk Pregnancies Recruiting
CEReBral AutorEgulation in Non-cardiac SuRgery and Relationship to Postoperative DeliriUm State Recruiting

Other trials for the same condition

Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03932383 on ClinicalTrials.gov ↗ ← All trials in Israel